Bio-Techne Surges After Merck KGaA Announces Cash Acquisition Offer
Bio-Techne (TECH) surged over 20% after German pharmaceutical giant Merck KGaA announced a $73-per-share cash acquisition offer. The deal, which is expected to boost Merck's pipeline and generate significant cost synergies, has driven investor optimism in the life sciences sector.
Tickers: $TECH
Topics: activist_investor Bio-Techne Merck KGaA stock_movement